Canadian Dermatology Centre
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ahluwalia, Renita
TAK-279-PsO-3003, NCT06550076: A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting
3
1300
Europe, Canada, Japan, US, RoW
TAK-279
Takeda
Plaque Psoriasis
05/26
05/26
TAK-279-3002, NCT06108544: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Active, not recruiting
3
1108
Europe, Canada, US, RoW
TAK-279, Placebo, Apremilast
Takeda
Plaque Psoriasis
12/24
11/25
NCT05430464: A Study of a Laser for the Treatment of Acne Vulgaris

Recruiting
N/A
30
Canada
1726nm Laser System, Sham Laser System
Cutera Inc., ethica Clinical Research Inc.
Acne Vulgaris
04/23
10/24
Mooney, Michelle
NCT05430464: A Study of a Laser for the Treatment of Acne Vulgaris

Recruiting
N/A
30
Canada
1726nm Laser System, Sham Laser System
Cutera Inc., ethica Clinical Research Inc.
Acne Vulgaris
04/23
10/24

Download Options